Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus

Mark J. Harrison, Yasmeen Ahmad, Sahena Haque, Nicola Dale, Lee Suan Teh, Neil Snowden, Pauline Ho, Rachel Gorodkin, Ian N. Bruce

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Objective. Preference-based measures, such as the Short Form-6D (SF-6D), allow quality-adjusted life-years, used in cost-utility evaluations, to be calculated. We investigated the construct and criterion validity of the SF-6D in patients with systemic lupus erythematosus (SLE). Methods. Female patients with SLE were recruited from outpatient clinics at 2 timepoints, 5 years apart. Cross-sectional correlation of the SF-6D with domains of the disease-specific LupusQol health-related quality of life (HRQOL) measure, the Systemic Lupus International Collaborating Clinics Damage Index (SDI; for damage) and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI; for activity) measures, and patient characteristics was tested. The ability to discriminate between groups defined by smoking status, presence/absence of carotid plaque, depression, and fatigue was tested using the t-test. Results. In total 181 patients were recruited at baseline. The SF-6D correlated moderately to strongly with all domains of the LupusQoL (0.6-0.8) apart from intimate relationships (0.42) and body image (0.34). Correlations of the SF-6D with the demographic and disease-specific measures at baseline were small for the SDI score (-0.23) and age (-0.19) and in the expected direction. The SF-6D did not correlate with disease activity (SLEDAI -0.08). The SF-6D could distinguish those who smoked, had carotid plaque, had depression, and reported fatigue from those who did not, with the largest effect size being for depression (0.75). Conclusion. The SF-6D displays construct and criterion validity for use in patients with SLE, but the low correlation with aspects of intimate relationships and body image represents a concern and reinforces the need to collect disease-specific measures of HRQOL alongside generic preference-based instruments. The Journal of Rheumatology Copyright © 2012. All rights reserved.
    Original languageEnglish
    Pages (from-to)735-742
    Number of pages7
    JournalJournal of Rheumatology
    Volume39
    Issue number4
    DOIs
    Publication statusPublished - Apr 2012

    Keywords

    • Health-related quality of life
    • Health-state utility
    • SF-6D
    • Systemic lupus erythematosus
    • Validity

    Fingerprint

    Dive into the research topics of 'Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus'. Together they form a unique fingerprint.

    Cite this